These results demonstrate the efficacy of selinexor and AMG510 or MRTX1257 combinations in three-dimensional (3D) cell growth models of KRAS G12C–mutant PDAC and NSCLC. This evidence concerns the gene KRAS and non-small cell lung carcinoma.